Bimatoprost
Showing 1 - 25 of 175
Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System
Recruiting
- Cataract
- +2 more
- Bimatoprost Implant System (High Dose)
- +4 more
-
Glendale, ArizonaArizona Advanced Eye Research Institute
Nov 8, 2023
Scars, Hypopigmented Scar, Hypopigmented Skin Trial in Washington (Bimatoprost, Saline)
Recruiting
- Scars
- +8 more
- Bimatoprost
- Saline
-
Washington, District of ColumbiaMedStar Washington Hospital Center
Nov 2, 2023
Healthy Volunteers Trial in Newark (Bimatoprost Ophthalmic)
Not yet recruiting
- Healthy Volunteers
- Bimatoprost Ophthalmic
-
Newark, New JerseyBiotrial
Feb 6, 2023
Alopecia Areata Trial in Cairo (Bimatoprost 0.03% solution, CO2 fractional laser)
Completed
- Alopecia Areata
- Bimatoprost 0.03% solution
- CO2 fractional laser
-
Cairo, EgyptAL-Azhar University Hospital
Oct 26, 2022
Open-angle Glaucoma Trial (Bimatoprost Sustained Release Implant)
Available
- Open-angle Glaucoma
- Bimatoprost Sustained Release Implant
- (no location specified)
Apr 13, 2022
Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Test - Bimatoprost 0.01% Ophthalmic Solution, Reference -
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Test - Bimatoprost 0.01% Ophthalmic Solution
- Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
-
Newport Beach, California
- +8 more
Aug 9, 2022
Vitiligo Trial in Charleston (Bimatoprost, Excimer laser, Microneedling with a dermaroller)
Completed
- Vitiligo
- Bimatoprost
- +2 more
-
Charleston, South CarolinaMedical University of South Carolina
Aug 3, 2022
Glaucoma, Ocular Hypertension Trial in Colombia, United States (Bimatoprost Ophthalmic)
Recruiting
- Glaucoma
- Ocular Hypertension
- Bimatoprost Ophthalmic
-
Philadelphia, Pennsylvania
- +7 more
Jul 18, 2022
Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost SR
- LUMIGAN
-
Dothan, Alabama
- +5 more
May 17, 2022
Open Angle Glaucoma Trial (NCX 470, Placebo)
Not yet recruiting
- Open Angle Glaucoma
- NCX 470
- Placebo
- (no location specified)
Jul 6, 2023
Dermatochalasis Trial in New Orleans (bimatoprost 0.03% ophthalmic solution)
Completed
- Dermatochalasis
- bimatoprost 0.03% ophthalmic solution
-
New Orleans, LouisianaTulane Department of Dermatology
Feb 12, 2021
Ocular Hypertension Glaucoma Trial in Stara Zagora (Bimatoprost Timolol (T4030), Bimatoprost Timolol (Ganfort))
Recruiting
- Ocular Hypertension Glaucoma
- Bimatoprost Timolol (T4030)
- Bimatoprost Timolol (Ganfort)
-
Stara Zagora, BulgariaMedical Center Vereya EOOD
May 18, 2021
Glaucoma, Open-Angle Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser
Completed
- Glaucoma
- Open-Angle Ocular Hypertension
- Bimatoprost SR
- +3 more
-
Dothan, Alabama
- +32 more
Feb 22, 2022
Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /
Completed
- Ocular Surface Disease
- Primary Open Angle Glaucoma
- Tafluprost, timolol maleate
-
Taoyuan city, TaiwanChang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022
Normal Tension Glaucoma Trial in Vestal (Netarsudil Ophthalmic, Bimatoprost Ophthalmic)
Not yet recruiting
- Normal Tension Glaucoma
- Netarsudil Ophthalmic
- Bimatoprost Ophthalmic
-
Vestal, New YorkRoberts Eyecare Associates
Aug 5, 2021
Glaucoma Trial in Miami (Latanoprost, Bimatoprost, Travoprost)
Active, not recruiting
- Glaucoma
- Latanoprost
- +7 more
-
Miami, FloridaBascom Palmer Eye Institute - University of Miami
Oct 7, 2021
Different Drugs on Ocular Surface Disease in Glaucoma
Recruiting
- Glaucoma; Ocular Disorders (I.E. Caused by Ocular Disorders)
- Lumigan PF; Xalatan
-
Taipei City, TaiwanNational Taiwan University Hospital
May 17, 2021
Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
Recruiting
- Open-angle Glaucoma
- Ocular Hypertension
-
Culver City, California
- +24 more
Feb 21, 2022
Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser
Active, not recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Bimatoprost SR
- +3 more
-
Dothan, Alabama
- +94 more
Nov 1, 2022
Alopecia, Breast Cancer Trial in Los Angeles (bimatoprost ophthalmic solution, )
Withdrawn
- Alopecia
- Breast Cancer
- bimatoprost ophthalmic solution
- placebo
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Jul 29, 2020
Open Angle Glaucoma, Ocular Hypertension Trial in United States (OTX-TIC low dose Travoprost Intracameral Implant, OTX-TIC high
Recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- OTX-TIC low dose Travoprost Intracameral Implant
- +2 more
-
Delray Beach, Florida
- +8 more
Apr 12, 2022
Glaucoma, Ocular Hypertension Trial in United States (latanoprost 0.005% ophthalmic solution, Travoprost 004% sterile ophthalmic
Completed
- Glaucoma
- Ocular Hypertension
- latanoprost 0.005% ophthalmic solution
- +2 more
-
Bellflower, California
- +39 more
Feb 1, 2021
Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)
Completed
- Primary Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost
- +3 more
-
Fayetteville, Arkansas
- +9 more
May 18, 2020